Pietsch, Adriana M.
Viehöver, Andrea
Diem, Ricarda
Weiler, Markus
Korporal-Kuhnke, Mirjam
Wildemann, Brigitte
Sam, Georges
Hayes, John M.
Fösleitner, Olivia
Jende, Johann M. E.
Heiland, Sabine
Bendszus, Martin
Hayes, Jennifer C. http://orcid.org/0000-0002-6254-9192
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 1158, SFB 1118, SFB 1158)
Medizinischen Fakultät Heidelberg, Universität Heidelberg (Olympia Morata, Rahel Goetein-Straus)
Medizinische Fakultät Heidelberg der Universität Heidelberg
Article History
Received: 17 March 2022
Accepted: 14 September 2022
First Online: 20 October 2022
Conflict of interest
: A. Viehöver received lecture honoraria from Roche and Merck. R. Diem received grants from the German Research Foundation (FOR 2289), the Hertie Foundation, and the German Ministry of Education and Research. M. Korporal-Kuhnke reports lecture honoraria from Novartis, BMS and Merck. O. Fösleitner received the Rahel Goetein-Straus stipend grant from the Medical Faculty of the University of Heidelberg. J.M.E. Jende received grants from the German Research Foundation (SFB 1158), and the International Foundation for Research in Paraplegia. S. Heiland received a research grant from the German Research Foundation (SFB 1118). B. Wildemann received grants from the German Ministry of Education and Research, German Research Foundation, Dietmar Hopp Foundation and Klaus Tschira Foundation, grants and personal fees from Merck, Sanofi Genzyme, Novartis, and personal fees from Alexion, Bayer, Biogen, Teva; none related to this work. M. Bendszus reports personal fees from Boehringer Ingelheim, grants and personal fees from Novartis, grants from Siemens, personal fees from Merck, personal fees from Bayer, grants and personal fees from Guerbet, grants from Hopp Foundation, grants from DFG, grants from European Union, grants from Stryker, personal fees from Teva, personal fees from BBraun, personal fees from Vascular Dynamics, personal fees from Grifols, personal fees from Neuroscios. J.C. Hayes received a research grant, personal fees, lecture honoraria and financial support for conference attendance from Alnylam Pharmaceuticals, the Olympia Morata stipend grant from the Medical Faculty of the University of Heidelberg, lecture honoraria and financial support for conference attendance from Pfizer, and advised for Akcea Therapeutics. A.M. Pietsch, M. Weiler, G. Sam and J.M. Hayes declare that they have no competing interests.